Form 4: UNH Director Gil Acquires Shares via Dividends

UnitedHealth Group Director Kristen Gil acquired 7 shares of common stock through dividend equivalents on vested deferred stock units.

Summary

• Kristen Gil, a Director of UnitedHealth Group Inc. (UNH), acquired 7 shares of common stock.
• The transaction occurred on December 16, 2025, at a price of $0 per share.
• These shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units.
• Following this transaction, Kristen Gil directly owns 1,907 shares and indirectly owns 3,800 shares through a trust.

Sentiment

Score: 6

Explanation: Slightly positive as a director's beneficial ownership increased, indicating continued alignment with shareholder interests, albeit through a routine, non-discretionary transaction.

Positives

• Director Kristen Gil's beneficial ownership of UnitedHealth Group common stock increased by 7 shares.
• The acquisition of shares through dividend equivalents demonstrates continued alignment of director interests with shareholders.

Negatives

• No negative information is disclosed in this Form 4 filing.

Risks

• This Form 4 filing does not contain information regarding company-specific risks.

Future Outlook

This filing is an insider transaction report and does not contain forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction is a routine event for publicly traded companies, reflecting a director's receipt of dividend equivalents on existing equity awards. It does not provide specific insights into broader industry trends or competitive landscape.

Comparison to Industry Standards

• The acquisition of shares through dividend equivalents is a standard practice for equity compensation plans across various industries.
• It aligns director incentives with shareholder value, a common corporate governance principle.
• No specific comparable companies or projects are relevant for this type of routine insider transaction.

Stakeholder Impact

• Shareholders: Minor positive impact due to increased director alignment with shareholder interests through additional equity ownership.
• Employees, Customers, Suppliers, Creditors: No direct impact from this routine insider transaction.

Next Steps

• This filing does not mention any specific future actions, events, or milestones.

Key Dates

Keywords

UnitedHealth Group, UNH, Kristen Gil, Director, Insider Transaction, Form 4, Common Stock, Dividend Equivalents, Deferred Stock Units, Beneficial Ownership